Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DS01GZ
|
|||
| Drug Name |
Dilanubicel
|
|||
| Synonyms |
NLA101
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 2 | [1] | |
| Company |
Nohla Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03301597) NLA101 in Adults Receiving High Dose Chemotherapy for AML (LAUNCH). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.